drugset / Trial / NCT00095056
An Investigational Drug in Patients With Type 2 Diabetes Mellitus and Chronic Renal Insufficiency (0431-028)(COMPLETED)
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to determine the safety and tolerability of an investigational drug in patients with Type 2 Diabetes Mellitus (a specific type of diabetes) and Chronic Renal Insufficiency (inadequate kidney function).
Timeline
- Start
- 2004-10
- Primary completion
- 2006-07
- Completion
- 2006-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Glipizide | Small molecule | 20 mg | — |
| Subject | Sitagliptin | Small molecule | 25 mg | — |
| Subject | Sitagliptin | Small molecule | 50 mg | — |